Performance of FDG-PET, SRS and CT for diagnosis of well differentiated endocrine carcinomas with high Ki67 (≥10%).

被引：0
|
作者：
Abgral, R. [1 ]
Leboulleux, S. [1 ]
Deandreis, D. [1 ]
Auperin, A. [1 ]
Dromain, C. [1 ]
Duvillard, P. [1 ]
Lumbroso, J. [1 ]
Schlumberger, M. [1 ]
Ducreux, M. [1 ]
Baudin, E. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S273 / S273
页数：1
相关论文
共 50 条
  • [21] A Phase II Study of Everolimus in Patients with FDG-PET Positive Intermediate Grade (Ki67 3-20%) Pancreatic Neuroendocrine Tumor
    Michael, M.
    Pavlakis, N.
    Wyld, D.
    Link, E.
    Liauw, W.
    Kuru, N.
    Hicks, R.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 132 - 132
  • [22] Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer
    Mayoral, M.
    Paredes, P.
    Saco, A.
    Fuste, P.
    Perlaza, P.
    Tapias, A.
    Fernandez-Martinez, A.
    Vidal, L.
    Ordi, J.
    Pavia, J.
    Martinez-Roman, S.
    Lomena, F.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 80 - 86
  • [23] Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT
    Kazuhiro Kitajima
    Koji Murakami
    Erena Yamasaki
    Yasushi Domeki
    Yasushi Kaji
    Satoru Morita
    Narufumi Suganuma
    Kazuro Sugimura
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36
  • [24] Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT
    Kitajima, Kazuhiro
    Murakami, Koji
    Yamasaki, Erena
    Domeki, Yasushi
    Kaji, Yasushi
    Morita, Satoru
    Suganuma, Narufumi
    Sugimura, Kazuro
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (03) : 362 - 372
  • [25] [18F]FDG-PET/CT Heterogeneity in Patients with Metastatic, Well-Differentiated Pancreatic Neuroendocrine Tumours
    Ortolani, S.
    Cingarlini, S.
    Citton, E.
    Crosara, S.
    De Robertis, R.
    Grego, E.
    Vallerio, P.
    D'Onofrio, M.
    Butturini, G.
    Landoni, L.
    Capelli, P.
    Zuffante, M.
    Ferdeghini, M.
    Salgarello, M.
    Tortora, G.
    NEUROENDOCRINOLOGY, 2016, 103 : 61 - 61
  • [26] PET+10 Study: Efficacy of Platin/Etoposide Combination in Well-Differentiated Pancreatic Neuroendocrine Tumors with Ki-67 ≥10%
    Roquin, G.
    Baudin, E.
    Lombard-Bohas, C.
    Cadiot, G.
    Dominguez, S.
    Guimbaud, R.
    Niccoli, P.
    Legoux, J. L.
    Rohmer, V
    Ruszniewski, P.
    Caroli-Bosc, F. X.
    Hentic, O.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 269 - 269
  • [27] Diffusion-weighted MRI is not superior to FDG-PET/CT for the detection of neck recurrence in well-differentiated thyroid carcinoma
    Vera, Pierre
    Edet-Sanson, Agathe
    Quieffin, Farzaneh
    Le Cloirec, Joseph
    Bertrand, Anne-Sophie
    Cailleaux, Martin
    Menard, Jean-Francois
    Lussey-Lepoutre, Charlotte
    Callonnec, Francoise
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 311 - 320
  • [28] Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review
    Haidar, Mohamad
    Al Mahmasani, Layal
    Chehade, Laudy
    Elias, Charbel
    El Jebai, Malak
    Temraz, Sally
    Charafeddine, Maya
    Al Darazi, Monita
    Shamseddine, Ali
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (06) : 471 - 479
  • [29] The Potential of Using Discordance of Estrogen PET (FES-PET) and Glucose PET (FDG-PET) Scans and Pathologic Characteristics Including HER2 and Ki67 To Predict for Hormone Insensitivity in Women with Metastatic Breast Cancer
    Tonkin, K. S.
    Joy, A. A.
    Basi, S. K.
    Fenton, D.
    Amanie, J.
    Mackey, J. R.
    Tankel, K.
    Deschenes, J.
    Mcewan, S.
    CANCER RESEARCH, 2010, 70
  • [30] Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using 18F-FDG PET/CT, EZRIN, and KI67
    Kim, Byung-Chul
    Kim, Jingyu
    Kim, Kangsan
    Byun, Byung Hyun
    Lim, Ilhan
    Kong, Chang-Bae
    Song, Won Seok
    Koh, Jae-Soo
    Woo, Sang-Keun
    CANCERS, 2021, 13 (11)
12345